|1.||Stuetz, Anton: 3 articles (08/2007 - 03/2004)|
|2.||Sierra-Paredes, Germán: 2 articles (01/2008 - 07/2006)|
|3.||Sierra-Marcuño, Germán: 2 articles (01/2008 - 07/2006)|
|4.||Wolff, Klaus: 2 articles (01/2006 - 03/2004)|
|5.||Graeber, Michael: 2 articles (01/2003 - 04/2002)|
|6.||Jarvis, Blair: 2 articles (01/2002 - 01/2002)|
|7.||Wellington, Keri: 2 articles (01/2002 - 01/2002)|
|8.||Stuetz, A: 2 articles (12/2001 - 01/2000)|
|9.||Graeber, M: 2 articles (04/2001 - 01/2000)|
|10.||Paul, C: 2 articles (03/2001 - 01/2000)|
|1.||Atopic Dermatitis (Atopic Eczema)
04/01/2001 - "Ascomycin: an advance in the management of atopic dermatitis."
03/01/2000 - "In particular, tacrolimus and ascomycin derivatives have been shown to be effective for treating atopic dermatitis with a surprising lack of side effects. "
01/01/2002 - "Pimecrolimus (SDZ ASM 981), an ascomycin derivative, is a nonsteroid, has anti-inflammatory activity, and has demonstrated efficacy in reducing symptoms of atopic dermatitis in adult and pediatric patients when applied topically. "
01/01/2002 - "Pimecrolimus (SDZ ASM 981), an ascomycin derivative, is a nonsteroid, has anti-inflammatory activity, and has demonstrated efficacy in reducing symptoms of atopic dermatitis in adult and paediatric patients when applied topically. "
08/01/2007 - "Pimecrolimus is an ascomycin macrolactam derivative that has been recently approved for the topical treatment of atopic dermatitis. "
04/01/2001 - "It is the first ascomycin macrolactam derivative under development for the treatment of inflammatory skin diseases. "
01/01/2000 - "Ascomycin derivatives represent a novel class of anti-inflammatory macrolactams currently under development for the treatment of skin diseases. "
12/01/1998 - "Ascomycin derivatives represent a novel class of anti-inflammatory macrolactams that are under development for the treatment of skin diseases. "
10/01/1998 - "Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases."
01/01/2005 - "Pimecrolimus (SDZ ASM 981), an ascomycin derivative, as one of the new classes of immunomodulating macrolactams, is specifically effective in the treatment of inflammatory skin diseases. "
|3.||Psoriasis (Pustulosis Palmaris et Plantaris)
01/01/2003 - "Pimecrolimus (Elidel, SDZ ASM 981), a new macrolactam ascomycin derivative, was highly effective in treating plaque-type psoriasis when applied under Finn-chamber occlusion. "
05/01/2002 - "Pimecrolimus, an ascomycin macrolactam derivative, is an inhibitor of T-cell and mast-cell activation, developed and launched by Novartis for the potential treatment of psoriasis and allergic, irritant and atopic dermatitis. "
11/01/1999 - "Pimecrolimus, an ascomycin macrolactam derivative, is an inhibitor of T-cell and mast cell activation under development by Novartis for the potential treatment of psoriasis and allergic dermatitis. "
03/01/2011 - "(iii) Tacrolimus and ascomycin help in treating inflammatory skin disease such as allergic contact dermatitis and psoriasis. "
08/01/1999 - "SDZ ASM 981, a novel ascomycin macrolactam derivative, has high anti-inflammatory activity in animal models of allergic contact dermatitis and shows clinical efficacy in atopic dermatitis, allergic contact dermatitis and psoriasis, after topical application. "
07/01/2006 - "Mean seizure duration and mean number of seizures were significantly reduced (P < 0.01) by microperfusion of 100 microM ascomycin. "
07/01/2006 - "Low concentrations (10 microM) of ascomycin did not prevent picrotoxin seizures, however, 50 and 100 microM ascomycin showed antiepileptic effect, completely suppressing seizures in 41.7% and 75% of the animals studied respectively. "
07/01/2006 - "After establishing individual picrotoxin seizure thresholds, ascomycin was continually microperfused into the rat hippocampus through microdialysis probes at concentrations 10, 50 and 100 microM. "
07/01/2006 - "The potential in vivo anticonvulsant effect of calcineurin (protein phosphatase 2B) inhibitor ascomycin against seizures induced by intrahippocampal microdialysis of picrotoxin was examined in the present study. "
07/01/2006 - "Anticonvulsant effect of the calcineurin inhibitor ascomycin on seizures induced by picrotoxin microperfusion in the rat hippocampus."
|5.||Immunosuppressive Agents (Immunosuppressants)